Impactful collaborations
Our program ventures could each have a major impact on global healthcare, and we are excited to take these first steps together.
Impactful collaborations
Our program ventures could each have a major impact on global healthcare, and we are excited to take these first steps together.

Winterlight Labs, based in Toronto, Canada, has developed a solution to analyse speech and detect subtle changes in speech patterns of patients with many neurological conditions.
Winterlight’s platform analyses both the acoustics and content of speech and language to assess progression or improvement in cognitive health and achieve more detailed measurement of a patient’s response to therapeutic interventions

PeakProfiling combines voice analytics based on quantitative musicology of sound patterns with Machine Learning methods. Several clinical studies have already demonstrated that this technology can serve as a valid predictor of certain clinical conditions.

VRx Medical is an immersive digital therapeutics company founded in California by Garland Wong and Paul Lafferty. Their mission is to deliver accessible, drug-free, digital wellness through immersive VR technology.
Bringing together virtual and augmented reality to the fingertips of patients, providing a wide range of therapies that can integrate into their lifestyles.

The miniature LAB-ON-SKINTM sensing platform developed by the Xsensio team in Lausanne, Switzerland, allows the detection of small changes in skin biofluids.
A non-intrusive wearable device that can help to detect and predict changes in a number of disease areas could help both clinicians and patients better manage a range of conditions and lead to better outcomes for patients.

Epihunter is a Belgium based digital healthcare company, focused on enabling people with brain disorders such as absence epilepsy to participate more fully in society.
The solution applies Al to third-party wearable EEG for real-time digital interventions, while generating data for better diagnosis, treatment, and new therapies.
JOIN US